GBT Announces Plans to Seek Regulatory Approval for Oxbryta® (voxelotor) to Treat Sickle Cell Patients in Europe
Intends to seek full marketing authorization for Oxbryta to treat hemolytic anemia in sickle cell diseaseMarketing Authorization Application submission planned by […]